Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Prostate Cancer Therapeutics Market, by Drug Type (Hormonal Therapy, Anti-androgens, Immunotherapy, Targeted Therapy, and Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Geography - Global Trends, and Forecast to 2025

Published Date : Jan 2018

Prostate Cancer Therapeutics Market Insights Prostate cancer is caused by the uncontrolled growth of the cells in the prostate gland. Prostate cancer is the most common cancer in men in the U.S., after skin c

Coherent Market Insights
Crohn's Disease Treatment Market, by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators & Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacy and e-Commerce), and by Region - Global Forecast to 2026

Published Date : May 2018

Crohn’s Disease Treatment Market – Global Insights Crohn’s disease is a form of inflammatory bowel disease (IBD) that refers to a chronic inflammatory condition of the gastrointestinal tract

Coherent Market Insights
U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B) and by Age Group (Pediatrics and Adults) - Trends, and Forecast till 2025

Published Date : Dec 2017

U.S. Influenza Vaccines Market– Prevention of Virus through Vaccination Aids in Reducing Burden of the Disease Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccinati

Coherent Market Insights
Global Enteral Nutrition Market, by Disease Type (Standard and Chronic), by Age Group (Below 15, 15 to 30, 30 to 45, 45 to 60, and Above 60), by End-use Industry (Hospitals, Clinics, and Long Term Care Facilities), by and Geography - Trends, and Forecast to 2025

Published Date : Dec 2017

Global Enteral Nutrition Market - Insights Enteral nutrition, also known as tube feeding refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including no

Coherent Market Insights
Middle East Tapentadol Market, by Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, and Others), and Cough Treatment), and by Countries - Trends and Forecast to 2025

Published Date : Nov 2017

Tapentadol - Become Pain Free! Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative

Coherent Market Insights
U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo

Coherent Market Insights
Global Medical Adhesives and Sealants Market, by Product Type (Synthetic and Natural), by Application (Internal, External and Dental), by End-use Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Dental Clinics, and Others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Medical Adhesives and Sealants Market – Providing Adhesive Solutions Post Surgeries Medical adhesives and sealants are commonly employed in medical practices for appliance bonding and surgical procedure

Coherent Market Insights
Global Clinical Nutrition Market by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Clinical Nutrition – The New Tradition is Good Nutrition Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vit

Coherent Market Insights
Chagas Disease Treatment Market, Product Type (Benznidazole, and Nifurtimox), Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) and by Region - Global Industry Insights, and Forecast till 2025

Published Date : May 2018

Chagas Disease Treatment Market - Insights Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-suck

Coherent Market Insights
Anti-epileptic Drugs for Pediatrics Market by Drug Type (1st generation, 2nd generation, and 3rd generation), and Region - Global Industry Insights, Trends, and Forecast, 2017-25

Published Date : Sep 2017

Anti-Epileptic Drugs for Pediatrics Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the brain obstructed by se

Coherent Market Insights
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Myelodysplastic Syndrome Treatment Market Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells call

Coherent Market Insights
Prophylactic Human Vaccine Market, By Vaccine Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Polysaccharide Vaccines, Conjugate Vaccines, and Recombinant Vaccines), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Prophylactic human vaccines stimulate the immune response and are intended for ameliorating the effects of future infection caused by pathogens in human beings. Novel vaccine development technologies such as viral-like particles are used in developing Hepatitis B Viru

Coherent Market Insights
Polymer-drug Conjugates Market, by Product Type (PEG-a-interferon 2b, 1 PEG-L-asparaginase, and PEG-GCSF), by Application (Cancers, Hepatitis, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Polymer-drug conjugates are nano-sized drug products currently used for treating cancer and hepatitis. Polymers are now being synthesized to be sensitive to specific enzymes that are apparent in diseased tissue. Conventional polymers are used in polymer-drug conjugate

Coherent Market Insights
Roxithromycin Market, by Indication (Urinary and Soft Tissue Infections, Respiratory Tract Infections, Pneumonia, and Otitis Media, and Sinusitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic, which prevents bacterial growth by interfering with protein synthesis. The drug is indicated to treat certain types of bacterial infections such as pharyngitis, sinusitis, bron

Coherent Market Insights
Pertuzumab Market, by Indication (Early Breast Cancer and Metastatic Breast Cancer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Pertuzumab is a recombinant monoclonal antibody that acts as an antineoplastic agent, which targets the human epidermal growth factor receptor 2 protein known as HER2. The drug blocks signaling pathways that leads to cell growth arrest and apoptosis (cell destruction)

Coherent Market Insights
Memantine Market, by Formulation (Tablet and Capsule), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Memantine is a non-acetyl cholinesterase inhibitor drug that aids in treatment of Alzheimer's disease. The drug received European marketing approval in 2002 and the U.S. Food and Drug Administration (U.S FDA) approval in 2003. The generic versions of the drugs are ava

Coherent Market Insights
Levodopa Market by Application (Parkinson’s disease and Dopamine Responsive Dystonia), by Drug Type (Rytary, Duopa, Sinemet, Canamet, and Others), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026.

To Be Published : Jul 2019

Levodopa or L-Dopa is a chemical building-block that converts into a dopamine in body. Dopamine is the chemical messenger released in brain. It mediates pleasure, cognition, and memory functions. Nearly all patients receive the dopamine precursor levodopa, which adequ

Coherent Market Insights
Fenbendazole Market, by Product Type (Powder, Tablet, and Liquid Formulations), by Application (Cattle, Sheep, Pig, Horse, Hens and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - SIze, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Fenbendazole is a broad spectrum anthelmintic drug of class benzimidazole. Fenbendazole is used to remove certain gastrointestinal parasites from the stomach and intestines of animals. It is effective against roundworms, hookworms, whipworms, certain tapeworms, and pa

Coherent Market Insights
Arginine Market, by Product Type (Food Grade and Pharma Grade), by Application (Supplements and Nutrition, Pharmaceuticals, and Cosmetics), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Arginine, which is also known as L-arginine, is an essential amino acid for humans. Arginine is present in all protein-containing foods such as grains, beans, nuts, meat, dairy products, and eggs, and it is also synthesized in the body from glutamine via citrulline am

Coherent Market Insights
Focal Segmental Glomerulosclerosis Market by Disease Type (Primary Focal Segmental Glomerulosclerosis, and Secondary Focal Segmental Glomerulosclerosis), by Drug (Sparsentan (Phase III)), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disease affecting the kidney's filtering system (glomeruli) and resulting in serious scarring and end stage renal disease. For instance, according to the article in Clinical Journal of American Society of Neph

Coherent Market Insights
Epidermolysis Bullosa Therapeutics Market, by Drugs (EB-101, Oleogel-S10 and Others), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Epidermolysis Bullosa (EB) is a rare, genetic disorder of skin tissues. People suffering from EB have fragile skin, which is susceptible to blisters leading to wounds that are difficult to heal. Symptoms related to this disorder includes, blistering of skin,

Coherent Market Insights
ALK Positive Lung Cancer Treatment Market by Drugs (Crizotinib, Alectinib, Ceritinib, and Brigatinib), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Clinics), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

ALK positive lung cancer treatment is used for people suffering from lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene). This gene mutation is due to gene rearrangement by fusion of two genes called as ALK and Echinoderm Microtubule-

Coherent Market Insights
Peptide Based Infection Therapeutics Market by Drug (Telaprevir, and Boceprevir), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Excessive and inappropriate use of antibiotics is creating antibiotic resistance among affected population at present. Therefore, the urge of developing novel therapies in fighting infections is increasing. A novel, peptide based therapies for treating infections has

Coherent Market Insights
Oncology Drug Pipeline Analysis Market, by Drug Class (Immunotherapy, Monoclonal Antibody, Antibody-Drug Conjugate, and Others), by Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others), by Route of Administration (Oral and Parenteral), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

The oncology field is witnessing rapid growth, owing to emergence of novel therapies with high efficacy, which in turn is boosting growth of the oncology drug pipeline market. For instance, in 2015, the U.S. Food and Drug Administration (U.S FDA) approved 45 New Molec

Coherent Market Insights
Corporate Wellness Market, by Service Type (Smoking Cessation, Weight Management, Fitness, Health Risk Assessment, Nutrition, Health Screening, and Others), by End User (Large-scale Organizations, Medium-scale Organizations, and Small-scale Organizations) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Corporate wellness are programs that are conducted in corporate offices to keep the employees healthy and happy, both physically and mentally. Currently, corporate wellness programs are largely adopted by employers to promote employee health, to reduce health related

Coherent Market Insights
H1N1 Vaccines Market, by Vaccine Type (Inactivated Vaccine and Live Attenuated Vaccine), by Route of Administration (Injection and Intranasal), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

H1N1 influenza virus causes viral disease, commonly known as swine flu, which mostly affects the respiratory system. Swine flu is characterized by infection from H1N1 strain. Symptoms of H1N1 flu are fever, cough, sore throat, runny or stuffy nose, watery and red eyes

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.